Strides Pharma’s Canadian Subsidiary Acquires 80% Stake in Pharmapar

Bangalore, India-headquartered Strides Pharma Sciences’ subsidiary Strides Pharma Canada Inc. has entered into an agreement to acquire an 80 per cent stake in Pharmapar Inc., a Quebec-based generic pharmaceuticals company. Canada is one of the top 10 global pharmaceutical markets, estimated at US$21 billion with a significant share of generics through retail pharmacies. Strides is an India-based pharmaceutical company with a major focus on the development and manufacture of patented dosage formulations.

Use 'AND' or 'OR' to refine your search.

Use quotes " " to get exact matches or remove them to get more results.